Cargando…
Discovery of genetic variants of the kinases that activate tenofovir among individuals in the United States, Thailand, and South Africa: HPTN067
Tenofovir (TFV), a nucleotide reverse transcriptase inhibitor, requires two phosphorylation steps to form a competitive inhibitor of HIV reverse transcriptase. Adenylate kinase 2 (AK2) has been previously demonstrated to phosphorylate tenofovir to tenofovir-monophosphate, while creatine kinase, musc...
Autores principales: | Figueroa, Dominique B., Tillotson, Joseph, Li, Maoji, Piwowar-Manning, Estelle, Hendrix, Craig W., Holtz, Timothy H., Bokoch, Kevin, Bekker, Linda-Gail, van Griensven, Frits, Mannheimer, Sharon, Hughes, James P., Grant, Robert M., Bumpus, Namandjé N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895070/ https://www.ncbi.nlm.nih.gov/pubmed/29641561 http://dx.doi.org/10.1371/journal.pone.0195764 |
Ejemplares similares
-
Short- and Long-Term Pharmacologic Measures of HIV Pre-exposure Prophylaxis Use Among High-Risk Men Who Have Sex With Men in HPTN 067/ADAPT
por: Velloza, Jennifer, et al.
Publicado: (2019) -
Factors Associated With Sex-Related Pre-exposure Prophylaxis Adherence Among Men Who Have Sex With Men in New York City in HPTN 067
por: Mannheimer, Sharon, et al.
Publicado: (2019) -
Discovery of Genetic Variants of the Kinases That Activate Tenofovir in a Compartment-specific Manner
por: Lade, Julie M., et al.
Publicado: (2015) -
A Mechanistic In Vivo/Ex Vivo Pharmacokinetic‐Pharmacodynamic Model of Tenofovir for HIV Prevention
por: Jayachandran, Priya, et al.
Publicado: (2021) -
Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study
por: Franks, Julie, et al.
Publicado: (2017)